Bracebridge Capital LLC’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bracebridge Capital LLC’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,000	Closed	-$1.4K	–	55
2023 Q3	$1.4K	Hold	25,000	–	–	﹤0.01%	46
2023 Q2	$3.69K	Buy	+25,000	New	+$2.59K	﹤0.01%	47

Bracebridge Capital LLC's BIOSW Position: Q4 2023 in Review

Bracebridge Capital LLC sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 25,000 shares — an estimated $1.4K sold.

Bracebridge Capital LLC first reported a position in BIOSW in Q2 2023 and held it in 2 quarters. The position peaked at $3.69K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Bracebridge Capital LLC reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Bracebridge Capital LLC sold 25,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $1.4K.
Bracebridge Capital LLC first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2023 and held it in 2 quarters.
Bracebridge Capital LLC's BioPlus Acquisition Corp. Warrants position peaked at $3.69K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Bracebridge Capital LLC's 13F filing for Q4 2023, filed 12 Feb 2024.